Deltagen Inc. (DGEN) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Deltagen Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.36M 1.99M 902,000 1.05M 1.02M
Cost of Goods Sold (COGS) incl. D&A - - - - 362,000
COGS excluding D&A - - - - 362,000
Depreciation & Amortization Expense 17,000 12,000 127,000 175,000 -
Depreciation - - - 175,000 0
Amortization of Intangibles - - - 0 -
Gross Income - - - - 660,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.64M 2.03M - 932,000 548,000
Research & Development 0 0 - - -
Other SG&A 1.64M 2.03M - 932,000 548,000
Other Operating Expense 407,000 640,000 - 0 -
Unusual Expense 0 0 0 0 -
EBIT after Unusual Expense 0 0 0 0 -
Non Operating Income/Expense 0 0 - 0 (3.71M)
Non-Operating Interest Income 16,000 9,000 - 1,000 -
Equity in Affiliates (Pretax) 0 0 - (1.11M) (823,000)
Interest Expense 0 0 - 0 -
Gross Interest Expense 0 0 - 0 -
Interest Capitalized 0 0 - 0 -
Pretax Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - - - 0 -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 - 0 -
Other After Tax Income (Expense) 0 0 - 0 -
Consolidated Net Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Minority Interest Expense 0 0 0 0 -
Net Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Extraordinaries & Discontinued Operations 0 0 0 0 -
Extra Items & Gain/Loss Sale Of Assets 0 0 - 0 -
Cumulative Effect - Accounting Chg 0 0 - 0 -
Discontinued Operations 0 0 0 0 -
Net Income After Extraordinaries (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Preferred Dividends 0 0 0 0 -
Net Income Available to Common (687,000) (685,000) (2.84M) (1.17M) (4.42M)
EPS (Basic) - - - - -
Basic Shares Outstanding - - - - -
EPS (Diluted) - - - - -
Diluted Shares Outstanding - - - - -
EBITDA (686,000) (682,000) (2.72M) 122,000 112,000
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Deltagen Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.36M 1.99M 902,000 1.05M 1.02M
Cost of Goods Sold (COGS) incl. D&A - - - - 362,000
COGS excluding D&A - - - - 362,000
Depreciation & Amortization Expense 17,000 12,000 127,000 175,000 -
Depreciation - - - 175,000 0
Amortization of Intangibles - - - 0 -
Gross Income - - - - 660,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.64M 2.03M - 932,000 548,000
Research & Development 0 0 - - -
Other SG&A 1.64M 2.03M - 932,000 548,000
Other Operating Expense 407,000 640,000 - 0 -
Unusual Expense 0 0 0 0 -
EBIT after Unusual Expense 0 0 0 0 -
Non Operating Income/Expense 0 0 - 0 (3.71M)
Non-Operating Interest Income 16,000 9,000 - 1,000 -
Equity in Affiliates (Pretax) 0 0 - (1.11M) (823,000)
Interest Expense 0 0 - 0 -
Gross Interest Expense 0 0 - 0 -
Interest Capitalized 0 0 - 0 -
Pretax Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - - - 0 -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 - 0 -
Other After Tax Income (Expense) 0 0 - 0 -
Consolidated Net Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Minority Interest Expense 0 0 0 0 -
Net Income (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Extraordinaries & Discontinued Operations 0 0 0 0 -
Extra Items & Gain/Loss Sale Of Assets 0 0 - 0 -
Cumulative Effect - Accounting Chg 0 0 - 0 -
Discontinued Operations 0 0 0 0 -
Net Income After Extraordinaries (687,000) (685,000) (2.84M) (1.17M) (4.42M)
Preferred Dividends 0 0 0 0 -
Net Income Available to Common (687,000) (685,000) (2.84M) (1.17M) (4.42M)
EPS (Basic) - - - - -
Basic Shares Outstanding - - - - -
EPS (Diluted) - - - - -
Diluted Shares Outstanding - - - - -
EBITDA (686,000) (682,000) (2.72M) 122,000 112,000
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
